These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 22146656)

  • 1. Cameron promotes new partnership between research, industry, and the NHS.
    Hawkes N
    BMJ; 2011 Dec; 343():d7956. PubMed ID: 22146656
    [No Abstract]   [Full Text] [Related]  

  • 2. Partnership between NHS and pharmaceutical sector is needed.
    Yamada T
    BMJ; 2001 Apr; 322(7291):930. PubMed ID: 11334035
    [No Abstract]   [Full Text] [Related]  

  • 3. Medicines regulation and the pharmaceutical industry.
    Breckenridge A; Woods K
    BMJ; 2005 Oct; 331(7520):834-6. PubMed ID: 16210285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Access to complementary health care: why the NHS is the key.
    Fox M
    Complement Ther Nurs Midwifery; 2001 Aug; 7(3):123-5. PubMed ID: 11855506
    [No Abstract]   [Full Text] [Related]  

  • 5. Public partnership with the NHS--1.
    Cumberlege J
    Hosp Health Serv Rev; 1987 Sep; 83(5):203-5. PubMed ID: 10284159
    [No Abstract]   [Full Text] [Related]  

  • 6. NHS criticised for lax control over drugs industry.
    Kmietowicz Z
    BMJ; 2005 Apr; 330(7495):805. PubMed ID: 15817534
    [No Abstract]   [Full Text] [Related]  

  • 7. Communications. Off message.
    Lloyd P
    Health Serv J; 1998 May; 108(5603):26-9. PubMed ID: 10179461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Public image limited.
    Salter B
    Health Serv J; 1993 Jul; 103(5361):28-9. PubMed ID: 10127740
    [No Abstract]   [Full Text] [Related]  

  • 9. Communications--hard news.
    Lloyd P
    Health Serv J; 1994 Jun; 104(5405):18-20. PubMed ID: 10134886
    [No Abstract]   [Full Text] [Related]  

  • 10. New image for the drug industry.
    Cohen D
    BMJ; 2011 Nov; 343():d7713. PubMed ID: 22127772
    [No Abstract]   [Full Text] [Related]  

  • 11. Using anonymized NHS data without consent: a step too far?
    McHale JV
    Br J Nurs; 2012 Jan 12-25; 21(1):54-5. PubMed ID: 22240524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NICE appraisals should be everybody's business.
    Wells J; Cheong-Leen C
    BMJ; 2007 May; 334(7600):936-8. PubMed ID: 17478847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A study in futility: Abigail Alliance for Better Access to Developmental Drugs will not expand access to experimental drugs for the terminally ill.
    Ochs A
    Seton Hall Law Rev; 2009; 39(2):559-603. PubMed ID: 19462540
    [No Abstract]   [Full Text] [Related]  

  • 14. THE NHS HAS A BLIND SPOT ON DRUG ACCESS FOR RARE CONDITIONS.
    Eaglen C
    Health Serv J; 2015 Sep; 125(6461):16-7. PubMed ID: 26642588
    [No Abstract]   [Full Text] [Related]  

  • 15. UK government tightens rules for drug regulators.
    Godfrey K
    BMJ; 2004 Nov; 329(7476):1203. PubMed ID: 15550411
    [No Abstract]   [Full Text] [Related]  

  • 16. Relationships with the drug industry: Collaboration to improve care.
    Coutts G
    BMJ; 2009 Feb; 338():b232. PubMed ID: 19193615
    [No Abstract]   [Full Text] [Related]  

  • 17. Decisions to be made. The new NHS and midwifery services.
    Coe L
    Pract Midwife; 2000 Nov; 3(10):34-6. PubMed ID: 12026493
    [No Abstract]   [Full Text] [Related]  

  • 18. Communications. Tell it like it is.
    Coombes R
    Health Serv J; 2005 Jun; 115(5960):43. PubMed ID: 16008194
    [No Abstract]   [Full Text] [Related]  

  • 19. How to step out of line and not step out of your job.
    Davies P
    Health Serv J; 2003 Sep; 113(5871):19. PubMed ID: 14577431
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmaceutical industry and the N.H.S.
    Lancet; 1967 Oct; 2(7519):766-8. PubMed ID: 4167266
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.